Tyra Biosciences Stock Analysis

TYRA Stock  USD 19.44  0.41  2.07%   
Tyra Biosciences is overvalued with Real Value of 18.39 and Target Price of 24.4. The main objective of Tyra Biosciences stock analysis is to determine its intrinsic value, which is an estimate of what Tyra Biosciences is worth, separate from its market price. There are two main types of Tyra Biosciences' stock analysis: fundamental analysis and technical analysis.
The Tyra Biosciences stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Tyra Biosciences' ongoing operational relationships across important fundamental and technical indicators.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tyra Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Tyra Stock refer to our How to Trade Tyra Stock guide.

Tyra Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The book value of Tyra Biosciences was at this time reported as 7.43. The company has Price/Earnings To Growth (PEG) ratio of 0.28. Tyra Biosciences recorded a loss per share of 1.69. The entity had not issued any dividends in recent years. Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California. Tyra Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 25 people. To find out more about Tyra Biosciences contact the company at 619 728 4760 or learn more at https://tyra.bio.

Tyra Biosciences Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Tyra Biosciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Tyra Biosciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Tyra Biosciences had very high historical volatility over the last 90 days
Net Loss for the year was (69.13 M) with profit before overhead, payroll, taxes, and interest of 0.
Tyra Biosciences currently holds about 275.11 M in cash with (50.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.61.
Over 99.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Tyra Biosciences Stock Price Down 3.3 percent - MarketBeat

Tyra Biosciences Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Tyra Biosciences previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
27th of March 2024
Upcoming Quarterly Report
2nd of May 2024
Next Financial Report
31st of December 2023
Next Fiscal Quarter End
27th of March 2024
Next Fiscal Year End
30th of September 2023
Last Quarter Report
31st of December 2022
Last Financial Announcement

Tyra Largest EPS Surprises

Earnings surprises can significantly impact Tyra Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Tyra Biosciences Environmental, Social, and Governance (ESG) Scores

Tyra Biosciences' ESG score is a quantitative measure that evaluates Tyra Biosciences' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Tyra Biosciences' operations that may have significant financial implications and affect Tyra Biosciences' stock price as well as guide investors towards more socially responsible investments.

Tyra Stock Institutional Investors

Orbimed Advisors, Llc2024-03-31
768.6 K
Perceptive Advisors Llc2024-03-31
669.2 K
Sio Capital Management, Llc2024-03-31
535.7 K
Kynam Capital Management, Lp2024-03-31
515.2 K
Geode Capital Management, Llc2024-03-31
416.8 K
First Turn Management Llc2024-03-31
381.2 K
Jpmorgan Chase & Co2024-03-31
380.6 K
State Street Corporation2024-03-31
292.2 K
Exoduspoint Capital Management, Lp2024-03-31
272.1 K
Ra Capital Management, Llc2024-03-31
10.4 M
Boxer Capital Llc2024-03-31
6.4 M
Note, although Tyra Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Tyra Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.02 B.

Tyra Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.31)(0.32)
Return On Capital Employed(0.38)(0.36)
Return On Assets(0.31)(0.32)
Return On Equity(0.34)(0.32)

Management Efficiency

Tyra Biosciences has return on total asset (ROA) of (0.1666) % which means that it has lost $0.1666 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2363) %, meaning that it created substantial loss on money invested by shareholders. Tyra Biosciences' management efficiency ratios could be used to measure how well Tyra Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of June 18, 2024, Return On Tangible Assets is expected to decline to -0.32. The current year's Return On Capital Employed is expected to grow to -0.36. At present, Tyra Biosciences' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 5.3 M, whereas Total Assets are forecasted to decline to about 179.4 M.
Last ReportedProjected for Next Year
Book Value Per Share 4.78  5.02 
Tangible Book Value Per Share 4.78  2.85 
Enterprise Value Over EBITDA(6.78)(7.12)
Price Book Value Ratio 2.90  3.04 
Enterprise Value Multiple(6.78)(7.12)
Price Fair Value 2.90  3.04 
Enterprise Value540 M567 M
The analysis of Tyra Biosciences' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Tyra Biosciences' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Tyra Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Return On Assets
Return On Equity

Technical Drivers

As of the 18th of June 2024, Tyra Biosciences has the Semi Deviation of 3.68, risk adjusted performance of 0.0249, and Coefficient Of Variation of 4185.7. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Tyra Biosciences, as well as the relationship between them.

Tyra Biosciences Price Movement Analysis

Execute Study
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Tyra Biosciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Tyra Biosciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Tyra Biosciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tyra Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tyra Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Tyra Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Daniel Bensen over a week ago
Disposition of tradable shares by Daniel Bensen of Tyra Biosciences at 20.0 subject to Rule 16b-3
Moran Susan over two weeks ago
Disposition of tradable shares by Moran Susan of Tyra Biosciences subject to Rule 16b-3
Daniel Bensen over a month ago
Disposition of 73093 shares by Daniel Bensen of Tyra Biosciences at 16.3066 subject to Rule 16b-3
Todd Harris over a month ago
Disposition of 12773 shares by Todd Harris of Tyra Biosciences at 16.1275 subject to Rule 16b-3
Todd Harris over two months ago
Acquisition by Todd Harris of 1880 shares of Tyra Biosciences at 6.579 subject to Rule 16b-3
Todd Harris over three months ago
Acquisition by Todd Harris of 1880 shares of Tyra Biosciences at 6.579 subject to Rule 16b-3
Daniel Bensen over three months ago
Disposition of tradable shares by Daniel Bensen of Tyra Biosciences at 20.0 subject to Rule 16b-3
Daniel Bensen over three months ago
Disposition of 1189 shares by Daniel Bensen of Tyra Biosciences at 20.0189 subject to Rule 16b-3
Daniel Bensen over three months ago
Disposition of 5063 shares by Daniel Bensen of Tyra Biosciences at 20.0778 subject to Rule 16b-3
Ra Capital Management Lp over three months ago
Conversion by Ra Capital Management Lp of 40 shares of Tyra Biosciences
Daniel Bensen over three months ago
Disposition of 5849 shares by Daniel Bensen of Tyra Biosciences at 20.128 subject to Rule 16b-3
Daniel Bensen over three months ago
Disposition of 745 shares by Daniel Bensen of Tyra Biosciences at 20.0 subject to Rule 16b-3

Tyra Biosciences Predictive Daily Indicators

Tyra Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Tyra Biosciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Tyra Biosciences Corporate Filings

10th of June 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
31st of May 2024
Report filed with the SEC to announce major events that shareholders should know about
9th of May 2024
Report filed with the SEC to announce major events that shareholders should know about
7th of May 2024
Report filed with the SEC to announce major events that shareholders should know about
18th of April 2024
Other Reports
5th of April 2024
Other Reports
19th of March 2024
Report filed with the SEC to announce major events that shareholders should know about
13th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities

Tyra Biosciences Forecast Models

Tyra Biosciences' time-series forecasting models are one of many Tyra Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tyra Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Tyra Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Tyra Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Tyra shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Tyra Biosciences. By using and applying Tyra Stock analysis, traders can create a robust methodology for identifying Tyra entry and exit points for their positions.
Last ReportedProjected for Next Year

Current Tyra Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Tyra analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Tyra analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
24.4Strong Buy5Odds
Tyra Biosciences current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Tyra analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Tyra stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Tyra Biosciences, talking to its executives and customers, or listening to Tyra conference calls.
Tyra Analyst Advice Details

Tyra Stock Analysis Indicators

Tyra Biosciences stock analysis indicators help investors evaluate how Tyra Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Tyra Biosciences shares will generate the highest return on investment. By understating and applying Tyra Biosciences stock analysis, traders can identify Tyra Biosciences position entry and exit signals to maximize returns.
Begin Period Cash Flow251.2 M
Common Stock Shares Outstanding42.7 M
Total Stockholder Equity204.3 M
Property Plant And Equipment Net8.2 M
Cash And Short Term Investments203.5 M
Cash58 M
Accounts Payable4.7 M
Net Debt-51.5 M
50 Day M A17.2961
Total Current Liabilities15.3 M
Other Operating Expenses79.9 M
Non Current Assets Total14.2 M
Non Currrent Assets OtherM
Stock Based Compensation13.5 M

Complementary Tools for Tyra Stock analysis

When running Tyra Biosciences' price analysis, check to measure Tyra Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tyra Biosciences is operating at the current time. Most of Tyra Biosciences' value examination focuses on studying past and present price action to predict the probability of Tyra Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tyra Biosciences' price. Additionally, you may evaluate how the addition of Tyra Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios